ARCHIVES

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

In the Cancer Centers: Rosen Moves To City Of Hope

November 1, 2013

Cancer Researchers Ask Congress for Full Bypass Budge Funding

April 27, 1990

In Brief: Bristol Has Change Of Heart, Agrees To Supply NCI With VP-16 Free For Group C Distribution

July 16, 1982

Cancer Cases To Double By 2050 As U.S. Population Ages, Annual Report Says.

May 17, 2002

Scientists Lose Credibility When “Fire Alarm” Pulled Too Early, ACS’s Brawley Says.

August 1, 2008

Gleevec Approved For Pediatric CML

May 23, 2003